|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|
| Current Assets | ||||
| Cash | ||||
| Due from Sponsor | ||||
| Related Party | ||||
| Total due from Sponsor | ||||
| Prepaid expenses | ||||
| Total Current Assets | ||||
| Trust account | ||||
| Deferred offering costs | ||||
| Trust account | ||||
| Total Assets | ||||
| Current Liabilities | ||||
| Accounts payable and accrued expenses | ||||
| Accrued offering costs | ||||
| Advances from related party | ||||
| Related party payable – administrative fee | ||||
| Promissory note – related party | ||||
| Franchise tax payable | ||||
| Income tax payable | ||||
| Total Current Liabilities | ||||
| Deferred tax liability | ||||
| Deferred underwriting fee payable | ||||
| Total Liabilities | ||||
| Class A common stock subject to possible redemption, $0.0001 par value; 100,000,000 shares authorized; 7,500,000 shares issued and outstanding (at redemption value of $10.36 and $10.25) at March 31, 2024 and December 31, 2023, respectively | ||||
| Stockholders’ Deficit | ||||
| Common stock value | ||||
| Class A Common Stock | ||||
| Class B Common Stock | ||||
| Additional paid in capital | ||||
| Accumulated deficit | ||||
| Total Stockholders’ Deficit | ||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
Loading...
